key: cord-0027873-8sz8ftrd
authors: Moman, Rajat N.; Michael Hooten, W.
title: Prescription for unguided mobile health applications
date: 2021-01-06
journal: Br J Anaesth
DOI: 10.1016/j.bja.2020.11.022
sha: 9275b7973a671b7a432c2498651e2a76028f45e4
doc_id: 27873
cord_uid: 8sz8ftrd

nan

EditordIn a recent issue of British Journal of Anaesthesia, Li and colleagues 1 discuss the use of digital health for patients with chronic pain during the coronavirus disease 2019 (COVID-19) pandemic. The authors rightly point out that the COVID-19 pandemic has led to isolation and that patients with chronic pain are particularly vulnerable to the negative effects of this pandemic. The authors make a timely suggestion that digital health platforms may offer a solution to patients with chronic pain who lack healthcare access. Their discussion includes specific types of platforms and their drawbacks. They make the case that telehealth requires too much capacity for a health system and is unsustainable. In the case of online health communities, they cite lack of regulatory oversight. They point to chatbots as a possible solution that allows for patient counselling, support, and symptom triage; yet, the cited intervention lacked a significant effect on the outcomes of pain intensity, painrelated impairment, and general well-being 2 when compared with a control condition. Lastly, they mention the important role of psychologists and therapists in the direct care of chronic pain patients.

The authors present a balanced discussion of alternative strategies for care delivery during the pandemic. However, outside of discussion limited to chatbots, we note the relative absence of information about unguided electronic health (eHealth) and mobile health (mHealth) applications, or applications that do not require clinician contact or feedback. These unguided applications avoid some of the drawbacks associated with other digital health interventions in that they do not demand clinician involvement and they have a modest effect on clinically relevant outcomes. We believe the results of our recent meta-analysis that explored unguided eHealth and mHealth applications can add to this discussion. 3 In this meta-analysis, our a priori study outcomes were designed based on the Initiative on Methods, Measurement, and Pain Assessment in Clinical Trials criteria for chronic pain clinical trials. 4 Our meta-analysis pooled outcomes from 17 different RCTs of 17 different eHealth and mHealth interventions. We Correspondence -e89 Table 1 Studies on unguided electronic and mobile health technologies for chronic pain from our meta-analysis 3 and their current availability. AHRQ, Agency for Healthcare Research and Quality; CJE, Council for Jewish Elderly; DOD, Department of Defense; LSDF, Life Sciences Discovery Fund; N, no; NHMRC, National Health and Medical Research Council; NIH, National Institutes of Health; REHSAM, Rehabilitering och Samordning; U, unknown; VA, Veterans Affairs; Y, yes. *The current Headzup application was available on Apple's application store, but not on Google Play. The application is designed to recruit teenagers with recurrent headaches for an NIH-funded study according to the application description. This differs from the indication studied in the publication included in our meta-analysis, which was low back pain. y The Livanda.se programme was published in two peer-reviewed articles; one article was included in the meta-analysis. found that these unguided interventions resulted in statistically significant, yet modest improvements in multiple clinical outcomes of importance to patients with chronic pain: pain intensity, depression, and pain catastrophising. Although these improvements were only modest, these technologies may be more desirable for patients who lack access to typical healthcare and are in need amidst a pandemic. An important barrier that patients and clinicians who are interested in eHealth and mHealth applications face is that applications that are studied and presented in the medical literature are not always available to patients. 5 With that in mind, we previously published a list 6 of eHealth and mHealth applications that were reported in our meta-analysis and are available to interested patients and clinicians (Table 1 ; search date: March 2019; see table 1 of Moman and colleagues 3 ). We hope this list will be a good starting place for clinicians interested in learning more and possibly incorporating these applications in their daily practice.

Digital health for patients with chronic pain during the COVID-19 pandemic

A smartphone-based health care chatbot to promote selfmanagement of chronic pain (SELMA): pilot randomized controlled trial

A systematic review and meta-analysis of unguided electronic and mobile health technologies for chronic paindis it time to start prescribing electronic health applications

Core outcome measures for chronic pain clinical trials: IMMPACT recommendations

mHealth: a strategic field without a solid scientific soul. A systematic review of pain-related apps

The major barrier facing patients and clinicians who are interested in utilization of electronic and mobile health technologies

All rights reserved. Thresholds of functional capacity using the four-question (modified) Duke Activity Status Index (M-DASI-4Q) as a screening tool: observations from the Measurement of Exercise Tolerance Before Surgery (METS) study

Department of Anaesthesia, Perioperative and Pain Medicine

Germany *Corresponding author. E-mail: bernhard.riedel@petermac.org Keywords: cardiopulmonary exercise testing; cardiovascular risk; Duke Activity Status Index

The authors declare that they have no conflicts of interest.EditordThe international, multicentre Measurement of Exercise Tolerance Before Surgery (METS) study 1 of 1401 patients scheduled for abdominal surgery showed that subjective assessment of functional capacity should not be used for preoperative risk assessment, with only 19.2% (95% confidence interval [CI], 14.2e25.0%) sensitivity for predicting functional capacity defined as peak VO 2 <14 mL kg À1 min À1 . The Duke Activity Status Index (DASI) had construct validity for predicting functional capacity in surgical patients and improved predictive ability for postoperative myocardial injury. Nevertheless, cardiopulmonary exercise testing (CPET) was superior to the DASI in predicting in-hospital moderate or severe complications. CPET, however, is a resource-intensive test and by its nature a high aerosolgenerating procedure with ramifications given the current coronavirus diseases 2019 (COVID-19) pandemic. The DASI